Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Single Dosing News

Single Dosing News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Single Dosing. Real-time updates on events, politics, business and more.

Regeneron and Alnylam Report Positive Interim Phase 1 Clinical Data on ALN-APP, an Investigational RNAi Therapeutic for Alzheimer's Disease and Cerebral Amyloid Angiopathy

April 26, 2023
- Single Doses of ALN-APP Demonstrated Dose-Dependent, Rapid and Sustained Reduction of sAPPα and sAPPβ in Cerebrospinal Fluid, with Up to 90% at Highest Dose to Date - - Encouraging... | April 26, 2023
United Kingdom United States Pushkal Garg Alexandra Bowie Christine Regan Lindenboom Yvonne Greenstreet
Source: marketscreener.com

Alnylam Pharmaceuticals, Inc.: Alnylam and Regeneron Report Positive Interim Phase 1 Clinical Data on ALN-APP, an Investigational RNAi Therapeutic for Alzheimer's Disease and Cerebral Amyloid Angiopathy

April 26, 2023
Single Doses of ALN-APP Demonstrated Dose-Dependent, Rapid and Sustained Reduction of sAPPa and sAPPß in Cerebrospinal Fluid, with Up to 90% at Highest Dose to Date Encouraging Clinical Safety and
United States United Kingdom Bryan Crowe Alexandra Bowie Yvonne Greenstreet Pushkal Garg
Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science